MCU and colon adenocarcinoma: Given the vital functions and the inconsistent reports of individual MCU complex members in the initiation and progression of malignancies, constructing a prognostic model based on MCU complex members might be an effective strategy to precisely predict the prognosis and benefits from immunotherapy in COAD.